Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

996 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The cost of HIV disease in Northern Italy: the payer's perspective.
Rizzardini G, Restelli U, Bonfanti P, Porazzi E, Ricci E, Casartelli L, Foglia E, Carenzi L, Citterio P, Orlando G, Maselli C, Croce D. Rizzardini G, et al. Among authors: ricci e. J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):211-7. doi: 10.1097/QAI.0b013e31821fdee2. J Acquir Immune Defic Syndr. 2011. PMID: 21546850
HIV and metabolic syndrome: a comparison with the general population.
Bonfanti P, Giannattasio C, Ricci E, Facchetti R, Rosella E, Franzetti M, Cordier L, Pusterla L, Bombelli M, Sega R, Quirino T, Mancia G. Bonfanti P, et al. Among authors: ricci e. J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):426-31. doi: 10.1097/QAI.0b013e318074ef83. J Acquir Immune Defic Syndr. 2007. PMID: 17514013
Negative influence of HIV infection on day-night blood pressure variability.
De Socio GV, Bonfanti P, Martinelli C, Ricci E, Pucci G, Marinoni M, Vitiello P, Menzaghi B, Rizzardini G, Schillaci G. De Socio GV, et al. Among authors: ricci e. J Acquir Immune Defic Syndr. 2010 Nov;55(3):356-60. doi: 10.1097/QAI.0b013e3181e46456. J Acquir Immune Defic Syndr. 2010. PMID: 20562709
HIV Clinical Pathway: A New Approach to Combine Guidelines and Sustainability of Anti-Retroviral Treatment in Italy.
Croce D, Lazzarin A, Rizzardini G, Gianotti N, Scolari F, Foglia E, Garagiola E, Ricci E, Bini T, Quirino T, Viganò P, Re T, D'Arminio Monforte A, Bonfanti P. Croce D, et al. Among authors: ricci e. PLoS One. 2016 Dec 28;11(12):e0168399. doi: 10.1371/journal.pone.0168399. eCollection 2016. PLoS One. 2016. PMID: 28030621 Free PMC article.
An Italian approach to postmarketing monitoring: preliminary results from the SCOLTA (Surveillance Cohort Long-Term Toxicity Antiretrovirals) project on the safety of lopinavir/ritonavir.
Bonfanti P, Martinelli C, Ricci E, Carradori S, Parruti G, Armignacco O, Magnani C, Quirino T; CISAI Group (Italian Coordinators for the Study of Allergies HIV Infection). Bonfanti P, et al. Among authors: ricci e. J Acquir Immune Defic Syndr. 2005 Jul 1;39(3):317-20. doi: 10.1097/01.qai.0000164248.56722.3c. J Acquir Immune Defic Syndr. 2005. PMID: 15980692
Cost-utility analysis of lopinavir/ritonavir versus atazanavir + ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: from randomised trial to real world.
Foglia E, Bonfanti P, Rizzardini G, Bonizzoni E, Restelli U, Ricci E, Porazzi E, Scolari F, Croce D. Foglia E, et al. Among authors: ricci e. PLoS One. 2013;8(2):e57777. doi: 10.1371/journal.pone.0057777. Epub 2013 Feb 27. PLoS One. 2013. PMID: 23460905 Free PMC article.
Four years data of raltegravir-based salvage therapy in HIV-1-infected, treatment-experienced patients: the SALIR-E Study.
Capetti A, Meraviglia P, Landonio S, Sterrantino G, Di Biagio A, Lo Caputo S, Ammassari A, Menzaghi B, De Socio GV, Franzetti M, Soria A, Meschiari M, Sasset L, Pellicanò G, Mazzotta E, Trezzi M, Celesia BM, Melzi S, Carenzi L, Ricci E, Rizzardini G. Capetti A, et al. Among authors: ricci e. Int J Antimicrob Agents. 2014 Feb;43(2):189-94. doi: 10.1016/j.ijantimicag.2013.10.013. Epub 2013 Nov 15. Int J Antimicrob Agents. 2014. PMID: 24315315
996 results